Clinical & translational oncology

• 

  Año 2013, Vol. 15, Número 2

  • MYC oncogene in myeloid neoplasias

    María Dolores Delgado Villar, Marta Albajar, María Teresa Gómez Casares, Ana Batllé López, Javier León Serrano

    • Resumen

    págs. 87-94

    

  • Radiotherapy in conjunction with superficial and intracavitary hyperthermia for the treatment of solid tumors: survival and thermal parameters

    S. Triantopoulou, E. Efstathopoulos, K. Platoni, N. Uzunoglou, N. Kelekis, Vassilios Kouloulias

    • Resumen

    págs. 95-105

    

  • The role of annexin A3 playing in cancers

    Na Wu, Shuqing Liu, Chunmei Guo, Zhijie Hou, Ming-Zhong Sun

    • Resumen

    págs. 106-110

    

  • Daily schedule for high-dose-rate brachytherapy in postoperative treatment of endometrial carcinoma

    Angeles Rovirosa Casino, Izaskun Valduvieco Ruiz, Carlos Ascaso Terrén, Antonio Herreros, C. Bautista, Ingrid Romera, Meritxell Arenas Prat, Jaume Pahisa, Alberto Biete Solà

    • Resumen

    págs. 111-116

    

  • Multicenter validation of two nomograms to predict non-sentinel node involvement in breast cancer

    Antonio Piñero Madrona, Manuel Canteras Jordana, Arancha Moreno, Francisco Vicente García, Julia Giménez Climent, Ana Tocino, Edelmiro Iglesias, Sergi Vidal Sicart, Luzdivina Santamaría Girón, Miguel Lorenzo Campos, Manuel García, Diego Ramírez

    • Resumen

    págs. 117-123

    

  • Human adipose tissue from normal and tumoral breast regulates the behavior of mammary epithelial cells

    Virginia Pistone Creydt, Sabrina Johanna Fletcher, Jimena Giudice, Ariana Bruzzone, Norma Alejandra Chasseing, Eduardo Gustavo González, Paula Alejandra Sacca, Juan Carlos Calvo

    • Resumen

    págs. 124-131

    

  • Quantitative analysis of EZH2 expression and its correlations with lung cancer patients� clinical pathological characteristics

    Liyan Wan, Xiao Li, Hong Shen, Xiaoyan Bai

    • Resumen

    págs. 132-138

    

  • Co-expression of MMP-14 and MMP-19 predicts poor survival in human glioma

    Liang Wang, Jun Yuan, Yanyang Tu, Xinggang Mao, Shiming He, Guoqiang Fu, Jianhai Zong, Yongsheng Zhang

    • Resumen

    págs. 139-145

    

  • Sorafenib for non-selected patient population with advanced hepatocellular carcinoma: efficacy and safety data according to liver function

    Jon Zugazagoitia, A. Manzano, Javier Sastre Valera, José María Ladero Quesada, Javier Puente Vázquez, Eduardo Díaz-Rubio García

    • Resumen

    págs. 146-153

    

  • Ultrasound-assisted endocavitary HDR-Ir192 brachytherapy for unresectable locally advanced uterine cervix carcinoma: retrospective analysis focusing the efficacy and tolerability

    Georgios V. Koukourakis, Anthoula Miliadou, Ioannis Tsalafoutas, Myrsini G. Gkeli, Anastasia Sotiropoulou-Lontou

    • Resumen

    págs. 154-159

    

  • Methylation in the p53 promoter in epithelial ovarian cancer

    Marcela Chmelarova, E. Krepinska, J. Spacek, J. Laco, M. Beranek, V. Palicka

    • Resumen

    págs. 160-163

    

  • CHEK2 c.1100delC mutation among non-BRCA1/2 Spanish hereditary breast cancer families

    Laura Fachal Vilar, M. Santamariña, Ángel Carracedo Álvarez, Ana Vega Gliemmo, A. Blanco

    págs. 164-165